Antineoplastic Combined Chemotherapy ProtocolsRadiation DosageRadiation, IonizingAntineoplastic AgentsRadiation InjuriesDose-Response Relationship, RadiationRadiation ToleranceChemotherapy, AdjuvantRadiationRadiation ProtectionRadiation MonitoringCombined Modality TherapyCisplatinNeoplasmsCell Line, TumorDoxorubicinBreast NeoplasmsDrug Resistance, NeoplasmDrug Screening Assays, AntitumorRadiation OncologyRadiotherapyTreatment OutcomeApoptosisLung NeoplasmsAntineoplastic Agents, PhytogenicCell SurvivalNeoplasms, Radiation-InducedEtoposideCosmic RadiationCyclophosphamideRadiotherapy DosagePaclitaxelRadiation Injuries, ExperimentalSurvival AnalysisGamma RaysRadiation PneumonitisMice, NudeDisease-Free SurvivalNeoplasm StagingSurvival RatePrognosisOvarian NeoplasmsAntibiotics, AntineoplasticXenograft Model Antitumor AssaysTumor Cells, CulturedRadiation-Sensitizing AgentsDNA DamageNeoplasm Recurrence, LocalColonic NeoplasmsNeoplasm MetastasisBackground RadiationTime FactorsDose-Response Relationship, DrugUltraviolet RaysRadiometryGene Expression Regulation, NeoplasticAntimetabolites, AntineoplasticDrug Administration ScheduleCarcinoma, Non-Small-Cell LungRadiotherapy, AdjuvantFollow-Up StudiesCarcinoma, Squamous CellAdenocarcinomaCamptothecinDrug Delivery SystemsVinblastineCell ProliferationEarly Detection of CancerStomach NeoplasmsOrganoplatinum CompoundsNeoadjuvant TherapyTaxoidsRadiation EffectsMethotrexateDeoxycytidineBrain NeoplasmsCarboplatinPancreatic NeoplasmsDrug Resistance, MultipleProstatic NeoplasmsNeoplasm ProteinsRadiation-Protective AgentsMutationAntineoplastic Agents, AlkylatingTumor Suppressor Protein p53Cell CycleBleomycinHead and Neck NeoplasmsClinical Trials as TopicCarcinomaDrug ResistanceColorectal NeoplasmsDrug SynergismNeoplasm TransplantationProspective StudiesP-GlycoproteinDNA RepairTumor Markers, BiologicalDose FractionationNeoplasm Invasiveness